Cegedim S.A. has entered a definitive merger agreement to acquire Dendrite International, Inc. for approximately $751 million in cash. The acquisition combines Cegedim’s European strength with Dendrite’s U.S. and Asia Pacific position, expanding sales, marketing, clinical and compliance solutions offered to the global life sciences and pharmaceutical industry. The combined company is expected to have estimated annual revenues of $1.1 billion and operate in more than 75 countries thr...